肾素-血管紧张素系统抑制剂对高血压患者脂代谢的改善作用(6)
[39] Parhofer KG, Münzel F, Krekler M. Effect of the angiotensin receptor blocker irbesartan on metabolic parameters in clinical practice: the DO-IT prospective observational study[J/OL]. Cardiovasc Diabetol, 2007, 6: 36. doi:10.1186/1475-2840-6-36.[40] Kintscher U, Bramlage P, Paar WD, et al. Irbesartan for the treatment of hypertension in patients with the metabolic syndrome: a sub analysis of the Treat to Target post authorization survey. Prospective observational ......
您现在查看是摘要页,全文长 3194 字符。